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Open access under CC BY licLaboratory-deﬁned biomarkers can greatly assist the diagnosis
and management of psychogenic movement disorders [1]. For
example, there are some neurophysiological ﬁndings that may
support the diagnosis of psychogenic tremor, including coactivation
of ﬁnger ﬂexors and extensors about 300 ms prior to tremor onset
[2]. In contrast, psychogenic dystonia has proven difﬁcult to distin-
guish from its organic counterpart, and there are no deﬁnitive,
simple tests [esupp Refs. 1–3] to support clinical diagnostic criteria
([3], esupp Refs. 4–5). Here, we describe an abnormal neurophysio-
logical pattern in a group of patients with ﬁxed lower limb dystonia
[4], a typical presentation of psychogenic dystonia ([5], esuppRef. 5).
We examined surface electromyogram recordings from the right
gastrocnemius, right tibialis anterior and left gastrocnemius
muscles from patients with either isolated ﬁxed (N ¼ 4; 3 females;
mean age 38 years; all negative for the DYT1 gene mutation) or
genetically determined and predominantly mobile (N ¼ 5; 3
females; mean age 35 years; all positive for the DYT1 gene muta-
tion) dystonia affecting the right lower limb, and from healthy
controls (N¼ 6; 4 females; mean age 30 years). None of the patients
with ﬁxed dystonia had complex regional pain syndrome, and none
of the diagnoses have been changed over a period of ten years after
the recordings were obtained.
Subjects placed their right foot in a customised open plaster-cast
that held it in a plantar-ﬂexed, inverted position, with a footplate
dynamometer placed underneath their foot. There were three study
conditions (“rest”, “posture” and “move”). Each condition included
auditory pacing cues (0.125 Hz) from a metronome for a duration
of 125 s. In the “move” condition, subjects were asked to make an
ipsilateral ﬂexion/extension movement of the ankle every 8 s, in
time with the metronome sound. For the “posture” condition,
subjects were asked to maintain their right foot in an inverted
plantar-ﬂexed posture. In the “rest” condition, subjects were
required to rest their feet. A pre-trial period of at least 30 s occurred
between the verbal instruction of the forthcoming condition and the
onset of themetronome. Each conditionwas repeated four times per
subject, in a counterbalanced order. Subjects gave written informed
consent, in accordance with the Declaration of Helsinki.
In two patients with ﬁxed dystonia, we found sustained muscle
coactivation of ipsilateral gastrocnemius, tibialis anterior, and contra-
lateral gastrocnemius muscles beginning towards the end of the pre-
trial period (Fig. 1). It occurred consistently prior to every repetition.ense.Moreover, it occurred before the “rest” condition, aswell as before the
“posture” and “move” conditions. None of the patients with organic
dystonia or controls demonstrated this coactivation pattern. Thus,
a coactivation sign, described in patients with psychogenic tremor
[2], is also found in a proportion of patients with ﬁxed dystonia.
The underlying pathophysiology of this coactivation
phenomenon remains to be established. In intermittent psycho-
genic tremor it has been postulated to underlie the pathophys-
iology of the tremor; however, since ﬁxed dystonia is also
present between conditions, it is unlikely to be the main mech-
anism underlying the generation of the abnormal posture. The
occurrence of prolonged coactivation even before the “rest”
condition suggests that it is distinct from preparation or motor
facilitation [esupp Ref. 2]. In ﬁxed dystonia, and possibly also
in psychogenic tremor, it may reﬂect an interaction between
attention to the affected limb and the motor system, leading
to further muscle contraction. This abnormal electromyographic
sign of pre-trial sustained coactivation encourages larger scale
investigation of this potential objective biomarker in psycho-
genic dystonia.
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Fig. 1. Representative footplate dynamometer (FP) and surface electromyogram recordings from right gastrocnemius (GN), tibialis anterior (TA) and contralateral gastrocnemius (C-
GN) muscles from a patient with ﬁxed dystonia of the right lower limb (FixD), demonstrating coactivation of GN, TA and C-GN muscles during the pre-trial period, preceding both
“rest” and “move” conditions and not seen between conditions. In contrast, traces depicting “move” trials in a patient with genetically determined dystonia of the right lower limb
(GenD) and a control subject (Con) show a lack of coactivation with onset during the pre-trial period. The pre-trial period (marked by vertical lines) spans the time between when
the subject was verbally informed of the condition, and the onset of the metronome. Each division on the abscissae denotes 25 s.
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